741. Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
作者: Lingyu Xu.;Stanislau Hrybouski.;Ting-Wei Ernie Liao.;Jessie N Dong.;Mirmilad Khoshknab.;David J Callans.;Francis E Marchlinski.;Walter R Witschey.;Benoit Desjardins.;Saman Nazarian.
来源: Circulation. 2025年152卷23期1608-1620页
A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We sought to characterize the geometric features of viable corridors, derived from late gadolinium enhanced cardiovascular magnetic resonance, that participate in VT circuitry in ischemic cardiomyopathy.
742. Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR.
作者: Antonin Trimaille.;Pedro Cepas-Guillén.;Juan Hernando Del Portillo.;Carlos Giuliani.;Jean-Michel Paradis.;Eric Dumont.;Anthony Poulin.;Dimitri Kalavrouziotis.;Frederic Beaupré.;Jean Porterie.;Siamak Mohammadi.;Josep Rodés-Cabau.
来源: Circ Cardiovasc Interv. 2025年18卷12期e015577页
While balloon postdilation (BPD) during transcatheter aortic valve replacement may enhance hemodynamic performance by optimizing valve expansion, it was also linked with leaflet mechanical stress, potentially reducing valve durability. The aim of this study was to investigate the impact of BPD on long-term bioprosthetic valve durability.
743. Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair.
作者: Donika Mustafa.;Jennifer von Stein.;Lukas Stolz.;Jean Marc Haurand.;Matthias Gröger.;Felix Rudolph.;Jannik Jobst.;Christoph Alexander Mues.;Amir Abbas Mahabadi.;Isabel A Hoerbrand.;Carl Schulz.;Atsushi Sugiura.;Philipp Lurz.;Tobias Kister.;Paula Sagmeister.;Charlotte Wolff.;Muhammed Gerçek.;Patrick Horn.;Mirjam Kessler.;Guido Ascione.;Tienush Rassaf.;Marcel Weber.;Niklas Schofer.;Mathias H Konstandin.;Florian Schindhelm.;Helge Möllmann.;Bernhard Unsöld.;Henning Guthoff.;Stephan Baldus.;Wolfgang Rottbauer.;Volker Rudolph.;Juan F Granada.;Jörg Hausleiter.;Roman Pfister.;Victor Mauri.;Philipp von Stein.; .
来源: Circ Cardiovasc Interv. 2025年18卷11期e015845页
Residual mitral regurgitation (rMR) ≤1+ has been associated with improved 1-year outcomes after mitral valve transcatheter edge-to-edge repair, regardless of the mean mitral pressure gradient (MPG). Prior evidence is limited to 30-day echocardiographic follow-up and patients treated with the MitraClip (Abbott Structural Heart). Whether rMR and MPG assessed at discharge are associated with outcomes after PASCAL mitral valve transcatheter edge-to-edge repair (Edwards Lifesciences) remains unknown.
744. Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association.
作者: Kristen L Knutson.;Debra D Dixon.;Michael A Grandner.;Chandra L Jackson.;Christopher E Kline.;Lisa Maher.;Nour Makarem.;Tami A Martino.;Marie-Pierre St-Onge.;Dayna A Johnson.; .
来源: Circulation. 2025年152卷21期e408-e419页
Cardiovascular and metabolic health are influenced by the circadian system, which regulates 24-hour rhythms across numerous physiologic processes. Disruptions to circadian rhythmicity can adversely affect cardiometabolic function and health. Given the importance of circadian health to overall human health, this scientific statement provides an overview of the circadian system and key behavioral factors that can synchronize or desynchronize these rhythms, including light exposure, food intake, physical exercise, and sleep timing. We also summarize the literature on associations between circadian health and cardiometabolic health indicators, such as excessive weight, type 2 diabetes (T2D), hypertension, and cardiovascular disease. We discuss strategies to improve circadian health and reduce circadian disruptions, focusing on interventions that target the key synchronizers of circadian rhythms and involve appropriate timing of exposure to these synchronizers. These include morning bright light exposure and avoidance of light at night, as well as appropriately timed sleep, meals, and exercise. Clinicians, researchers, policymakers, and the public should recognize the role of circadian rhythms in maintaining and promoting cardiometabolic health and focus on identifying modifiable behaviors that can improve them.
745. Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials.
作者: Yuko Kiyohara.;Tadao Aikawa.;Tetsuya Saito.;Abel Casso Dominguez.;Jose Wiley.;Dhaval Kolte.;Eric A Secemsky.;Robert W Yeh.;Roger J Laham.;Azeem Latib.;Deepak L Bhatt.;Toshiki Kuno.
来源: Circ Cardiovasc Interv. 2026年19卷1期e016005页
It remains unclear whether drug-coated balloons (DCBs) and drug-eluting stents are comparable in the treatment of coronary artery disease (CAD) and whether limus versus paclitaxel DCBs yield similar clinical outcomes. We aimed to assess the clinical efficacy of limus and paclitaxel DCBs in patients with CAD through a network meta-analysis.
746. The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
作者: Christopher A Rajkumar.;Michael J Foley.;Fiyyaz Ahmed-Jushuf.;Shayna Chotai.;Florentina A Simader.;Muhammad Mohsin.;Ahmed Salih.;Sashiananthan Ganesananthan.;Nina Bual.;Ricardo Petraco.;Sukhjinder S Nijjer.;Sayan Sen.;Joban Sehmi.;Neil Ruparelia.;Jason N Dungu.;Alamgir Kabir.;Kare Tang.;Reto Gamma.;John R Davies.;Tushar Kotecha.;Graham D Cole.;James P Howard.;Thomas R Keeble.;Gerald J Clesham.;Peter D O'Kane.;Frank E Harrell.;Darrel P Francis.;Matthew J Shun-Shin.;Rasha K Al-Lamee.
来源: Circulation. 2025年152卷22期1541-1551页
Little correlation exists between the burden of ischemia and severity of angina in patients with stable coronary artery disease. This placebo-controlled, n-of-1 study investigated the relationship between ischemia, the collateral circulation, and symptoms in stable coronary artery disease. Additionally, it explored the association between progressive collateral recruitment and ischemic preconditioning.
751. Surgery for Periprocedural Failure of Transcatheter Aortic Valve Replacement in the United States.
作者: Thomas A Schwann.;Robert H Habib.;Siavash Saadat.;Amr E Abbas.;Mario F L Gaudino.;Daniel T Engelman.;Aaron Kugelmass.;Milo Engoren.
来源: Circulation. 2025年152卷17期1262-1264页 756. Prognostic Utility of Quantitative Perfusion PET in Patients With Prior CABG: Incremental Value of Myocardial Flow Reserve and Coronary Vascular Resistance.
作者: Yoshito Kadoya.;Edgar Da Silva.;Lulwa A AlTakroni.;Nuha Hejji.;Kevin E Boczar.;Benjamin J W Chow.;Robert A deKemp.;Terrence D Ruddy.;Rob S Beanlands.;Gary R Small.
来源: Circ Cardiovasc Imaging. 2025年18卷12期e018204页
The prognostic utility of quantitative positron emission tomography (PET) with myocardial blood flow (MBF) measurements in patients with prior coronary artery bypass grafting remains unestablished. We evaluated PET-derived myocardial flow reserve (MFR) and coronary vascular resistance (CVR) for risk stratification in patients who have undergone coronary artery pass grafting.
757. Transcatheter Valve Replacement in Adults With Congenital Heart Disease-The Mayo Clinic Experience.
作者: Alexander C Egbe.;Allison K Cabalka.;Nathaniel W Taggart.;Donald J Hagler.;Mackram F Eleid.;Charanjit S Rihal.;Jason H Anderson.
来源: Circ Cardiovasc Interv. 2025年18卷12期e015667页
The current study aims to describe outcomes after transcatheter valve replacement in adults with congenital heart disease.
758. Giant Aberrant Vascular Structure Extending From the Left Ventricular Apex to the Umbilicus in a Newborn With Cantrell Pentalogy: Management and Transcatheter Closure.
作者: Hüseyin Pür.;Çağdaş Vural.;Ali Baykan.;Fatma Sena Topçu.;Duran Tavut.;Olgun Kontaş.;Mehmet Mutlu.
来源: Circ Cardiovasc Interv. 2025年18卷11期e015379页 759. Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial.
作者: Josep Rodés-Cabau.;Luis Nombela-Franco.;Ignacio Cruz-Gonzalez.;Benjamin Hibbert.;Xavier Freixa.;Jean-Bernard Masson.;Réda Ibrahim.;Rodrigo Estevez-Loureiro.;Xavier Millan.;Malek Kass.;Jean-Michel Paradis.;Jean Champagne.;Pablo Salinas.;Ana Laffond.;Omar Abdel-Razek.;Marino Labinaz.;Pedro Cepas-Guillen.;Dabit Arzamendi.;Pablo Vidal-Cales.;Marco Pavesi.;Mélanie Côté.;Gilles O'Hara.;Erwan Salaun.
来源: Circulation. 2025年152卷25期1759-1768页
The optimal antithrombotic treatment after transcatheter left atrial appendage closure (LAAC) remains to be determined. The objective of this trial was to compare anticoagulation and antiplatelet therapy for preventing device-related thrombosis (DRT) after LAAC.
760. Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions.
作者: Kazumasa Ikeda.;Takuya Mizukami.;Koshiro Sakai.;Frederic Bouisset.;Jeroen Sonck.;Adriaan Wilgenhof.;Hitoshi Matsuo.;Toshiro Shinke.;Hirohiko Ando.;Masahiro Hada.;Brian Ko.;Simone Biscaglia.;Fernando Rivero.;Thomas Engstrøm.;Antonio Maria Leone.;Lokien X van Nunen.;William F Fearon.;Evald Høj Christiansen.;Stephane Fournier.;Liyew Desta.;Andy Yong.;Julien Adjedj.;Javier Escaned.;Masafumi Nakayama.;Ashkan Eftekhari.;Danielle Keulards.;Frederik M Zimmermann.;Tatyana Storozhenko.;Bruno R da Costa.;Gianluca Campo.;Colin Berry.;Damien Collison.;Thomas W Johnson.;Daniel Munhoz.;Tetsuya Amano.;Divaka Perera.;Allen Jeremias.;Ziad A Ali.;Takashi Kubo.;Kazuhiro Satomi.;Nobuhiro Tanaka.;Bernard De Bruyne.;Nils P Johnson.;Carlos Collet.
来源: Circ Cardiovasc Interv. 2025年18卷12期e016022页
Impaired flow following percutaneous coronary intervention (PCI) is a known predictor of adverse outcomes. The pullback pressure gradient (PPG) is a novel physiological metric that differentiates focal from diffuse disease and enables prediction of post-PCI fractional flow reserve (FFR). This post hoc analysis of the PPG Global (NCT04789317) study aimed to evaluate the prognostic performance of a PPG model for predicting post-PCI FFR and to determine whether the predicted physiological outcome is associated with adverse events following PCI.
|